HRT FINANCIAL LP purchased $30K of SHPH
HRT FINANCIAL LP purchased 8,997 shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at an average of $3.36 ($3.11–$3.38) across 2 trades over 2026-07-09 to 2026-07-10.
How this was made
The 30-second read
Why it matters
A 10% owner reported an open-market purchase of 8,997 shares across two trades at $3.1100 to $3.3800, totaling $30,212.49, with holdings after the transaction of 61,271 shares.
Market read
Traders may treat this as a modest positive sentiment datapoint, but the disclosed value is small and lacks fundamental follow-through in the provided text.
What to watch
The filing notes no pre-arranged 10b5-1 plan, but the transaction size is still small, and there is no accompanying operational or financial update in the text.
Background
The article is an SEC Form 4 insider transaction disclosure for Shuttle Pharmaceuticals Holdings, Inc. (SHPH).
Ticker impact
HRT Financial LP, a 10% owner, filed a Form 4 showing an open-market purchase of 8,997 SHPH shares for about $30.2K (Jul 9-10).
Likely limited near-term impact; any effect would be modest and sentiment-driven unless followed by larger transactions.
Form 4 is primary-source and newly disclosed today, but the transaction value (~$30K) is relatively minor versus typical market-moving thresholds. Still, a 10% owner buying can modestly support sentiment and short-term positioning.
Market effects
No direct sector read-through; this is company-specific insider activity.
None indicated.
None indicated.
Counterpoint
A small open-market buy by a large holder may reflect routine portfolio rebalancing or liquidity needs rather than a strong forward outlook.
Key entities
- issuerShuttle Pharmaceuticals Holdings, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderHRT Financial LP
10% owner who purchased SHPH shares in open-market trades.
- filingSEC Form 4
Primary-source insider transaction report filed July 13, 2026.